FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $270,000 | -20.4% | 112,536 | +24.3% | 0.00% | – |
| Q1 2019 | $339,000 | +11.9% | 90,509 | +49.6% | 0.00% | – |
| Q2 2018 | $303,000 | +30200.0% | 60,488 | +27774.7% | 0.00% | – |
| Q3 2017 | $1,000 | -98.2% | 217 | -98.2% | 0.00% | – |
| Q2 2017 | $55,000 | +685.7% | 11,806 | +1832.2% | 0.00% | – |
| Q4 2016 | $7,000 | -99.4% | 611 | -99.7% | 0.00% | – |
| Q1 2016 | $1,232,000 | -26.3% | 188,925 | -8.3% | 0.00% | – |
| Q4 2015 | $1,671,000 | -67.5% | 206,000 | -71.9% | 0.00% | -100.0% |
| Q4 2014 | $5,138,000 | +57.1% | 732,890 | +22.1% | 0.00% | 0.0% |
| Q3 2014 | $3,270,000 | – | 600,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |